NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-072-2010-0-US-01 A Multifactorial Multidrug Resistance Gene Set Predicts Overall Survival In Ovarian Primary Serous Carcinoma US 61/308,946 Abandoned
NIDDK E-116-2010-0-US-01 Natural Product Inhibitors Of Drug-susceptible And Drug-resistant Bacteria And The Bacterial Cytoskeletal Protein FtsZ US 61/308,911 Abandoned
NIA E-089-2009-0-US-03 SPANX-B Polypeptides And Their Use US National Stage 13/203,042 8664183 Issued PDF
NCI E-221-2005-1-US-02 Fast Electron Paramagnetic Resonance Imaging (EPRI) Using CW CPR Spectrometer With Sinusoidal Rapid-scan And Digital Signal Processing US National Stage 12/306,514 8269496 Issued PDF
NIA E-089-2009-0-PCT-02 SPANX-B Polypeptides And Their Use PCT PCT PCT/US2010/025633 Expired
NIAMS E-309-2006-2-US-02 Cell-Nanofiber Composite And Cell-Nanofiber Composite Amalgam Based Engineered Intervertebra Disc US National Stage 12/443,393 Abandoned
NEI E-113-2010-0-US-01 Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Cosmetic Tanning US 61/308,771 Abandoned
NCI E-239-2009-0-US-01 DNA-Protein Vaccination Protocols US 61/308,853 Abandoned
NHLBI E-259-2007-0-US-03 Nitrite And Nitrite-methemoglobin Therapy To Detoxify Stroma-free Hemoglobin Based Blood Substitutes" US National Stage 12/675,347 8551536 Issued PDF
NCI E-113-2003-1-US-02 Target Activated Microtransfer US DIV 12/713,105 8460744 Expired PDF
NIAID E-125-2009-0-PCT-02 Francisella Tularensis Variants: Compositions and Methods of Use PCT PCT PCT/US10/25417 Expired
NCI E-302-2007-0-US-06 Compounds For Inhibiting Wip1, Prodrugs And Compositions Thereof, And Related Methods US National Stage 12/675,167 Abandoned
NINDS E-153-2005-2-US-05 Treatment of Inflammation, Demyelination and Neuronal/Axonal Loss US National Stage 12/444,854 Abandoned
NIMH E-185-2007-0-US-03 ARHGAP4 Is A Novel RhoGAP That Mediates Inhibition Of Cell Motility And Axon Outgrowth US National Stage 12/516,000 Abandoned
NIAID E-073-2010-0-US-01 A Peroxidase/dual Oxidase System Modulates Gut Epithelial Immunity In
Anopheles Gambiae. 		US 61/308,249 Abandoned
NHLBI E-251-2009-0-US-01 "Azicon": Beam Polarization Device For Superresolution Microscopy
improvements 		US 61/308,202 Abandoned
NCI E-104-2009-0-PCT-02 MicroRNAs in Never-Smokers and Related Materials and Methods PCT PCT PCT/US2010/025173 Expired
NCI E-104-2009-0-EP-04 MicroRNAs in Never-Smokers and Related Materials and Methods EP National Stage 10746739.1 Abandoned
NCI E-104-2009-0-CA-08 MicroRNAs in Never-Smokers and Related Materials and Methods CA National Stage 2753562 Abandoned
NCI E-104-2009-0-AU-03 MicroRNAs in Never-Smokers and Related Materials and Methods AU National Stage 2010218147 Abandoned
CC E-057-2009-0-PCT-02 METHODS FOR LOADING CONTRAST AGENTS INTO A LIPOSOME PCT PCT PCT/US2010/025049 Expired
CC E-057-2009-0-US-03 Methods For Loading Contrast Agents Into Drug Containing Liposomes US National Stage 13/202,920 Abandoned
NINR E-023-2010-0-US-01 A Gene Expression Biomarker Panel For Diagnosis Of Acute Ischemic Stroke US 61/307,233 Expired
NCI E-280-2007-0-US-02 Beta 1,4 Galactosyltransferases with Altered Donor and Acceptor Specificities, Compositions and Methods of Use US National Stage 12/674,655 8512991 Abandoned PDF
NCI E-279-2007-0-US-02 Alpha 1- 3 N- Galactosyltransferase with Altered Donor Specificities US National Stage 12/674,638 8425901 Abandoned PDF
NIDDK E-102-2011-0-US-01 COMPOSITIONS AND METHODS TO TREAT CARDIAC DISEASES US 61/306,687 Abandoned
NCI E-065-2005-4-EP-02 NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES EP National Stage 10744355.8 Abandoned
NCI E-065-2005-4-GB-07 NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES GB EP 10744355.8 Abandoned
NCI E-065-2005-4-DE-05 NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES DE EP 10744355.8 Abandoned
NCI E-065-2005-4-FR-06 NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES FR EP 10744355.8 Abandoned
NIA E-219-2008-0-EP-04 Method For The Diagnosis of Age-Associated Vascular Disorders EP National Stage 10705514.7 Abandoned
NIAID E-131-2002-0-US-10 Methods of Treating and Preventing Colitis Involving IL-13 and NK-T Cells US CON 12/709,029 8173123 Abandoned PDF
NIAID E-114-2009-0-PCT-02 Method And Medium For Host Cell-free (axenic) Growth Of Coxiella Burnetii PCT PCT PCT/US2010/024706 Expired
NIA E-219-2008-0-PCT-02 Method For The Diagnosis of Age-Associated Vascular Disorders PCT PCT PCT/US2010/024816 Expired
NCI E-065-2005-4-PCT-01 NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES PCT PCT COMB PCT/US2010/024729 Expired
NEI E-154-2007-0-US-03 Methods For Treatment Of Degenerative Disease Associated With Apoptosis US National Stage 12/674,331 Abandoned
NIAID E-086-2009-1-PCT-01 Use Of HIV/SIV Mosaic Gag Proteins To Optimize Vaccine-induced T Cell Responses Against HIV Gag PCT PCT COMB PCT/US10/24591 Expired
NHGRI E-007-1999-2-JP-08 Cellular Arrays and Methods of Detecting and Using Genetic Disorder Markers JP DIV 2010-033200 Abandoned
NIA E-005-2008-0-US-03 REGULATION OF RELEASE OF GLP-I AND SGLT-l FROM ENTEROENDOCRINE CELLS IN RESPONSE TO AGENTS ACTING ON TASTE SIGNALING MOLECULES In THE Gut US National Stage 12/674,152 Abandoned
NIAID E-248-2006-0-US-05 Modified Vaccinia Ankara (MVA) Virus Recombinants Comprising Heterologous Coding Sequences Inserted Into the Intergenic Regions Between Essential Genes US National Stage 12/377,847 9133478 Issued PDF
NCI E-290-2007-1-US-01 Method of Treating Disease Involving Myelin And/Or Axonal Loss US CIP 12/706,068 Abandoned
NCI E-057-1994-3-JP-09 MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS JP DIV 2010-031273 Abandoned
NINDS E-182-2007-0-US-06 Methods For Promoting Stem Cell Proliferation And Survival US National Stage 12/673,576 Abandoned
NCI E-023-2009-0-PCT-02 Molecular-Based Methods of Cancer Diagnosis and Prognosis PCT PCT PCT/US2010/024026 Expired
NCI E-159-2010-0-US-01 Multimeric Proteins Comprising Immunoglobulin Constant Domains US 61/304,302 Abandoned
NHLBI E-011-2010-0-US-01 The Optimized Codon Usage Of B19V Capsid Genes In Non-pennissive Cells And Its Application In Developing Virus-like Particle (VLP)-and DNA-based Vaccines Against B19V Infection US 61/337,983 Abandoned
NCI E-082-2010-0-US-01 CP-690550-mediated Suppression Of An Antibody Response To A Foreign Protein (antibody-toxin Protein) US 61/304,293 Abandoned
NCI E-194-2007-0-US-03 Trifunctional Imaging Agent For Monoclonal Antibody Tumor-Targeted Imaging US National Stage 12/667,790 8535639 Abandoned PDF
NCI E-186-2007-2-US-05 Papillomavirus Pseudoviruses For Detection And Therapy Of Tumors US National Stage 12/598,684 8394411 Issued PDF
NIDCD E-084-2009-0-PCT-02 Diagnostic And Therapeutic Uses Of GNPTAB, GNPTG, And NAGPA In Stuttering PCT PCT PCT/US10/23437 Expired